CIK 0000949858 · Non-accelerated filer<br>Smaller reporting company
ACHIEVE LIFE SCIENCES, INC.
Sign in to watch- Ticker
- ACHV
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954343413
- Phone
- 425-686-1500
- Business address
- 22722 29TH DR. SE, SUITE 100, SEATTLE, WA, 98021
- Former names
- ONCOGENEX PHARMACEUTICALS, INC., SONUS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $175,177
- in 1 filing
Net −$175,177. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-03-14 | HIMES VAUGHN B Director | Grant or award · Stock Option (right to buy) | +6,600 | 6,600 | ||
| 2022-03-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-03-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-03-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-02-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-02-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-02-01 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-01-03 | Clarke Anthony CSO | Grant or award · Performance Restricted Stock Unit (PRSU) | +7,500 | 7,500 | ||
| 2022-01-03 | Clarke Anthony CSO | Grant or award · Stock Option (right to buy) | +7,500 | 7,500 | ||
| 2022-01-03 | Wan Jerry Principal Accounting Officer | Grant or award · Performance Restricted Stock Unit (PRSU) | +11,250 | 11,250 | ||
| 2022-01-03 | Wan Jerry Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +11,250 | 11,250 | ||
| 2022-01-03 | JACOBS CINDY President & CMO | Grant or award · Performance Restricted Stock Unit (PRSU) | +32,500 | 32,500 | ||
| 2022-01-03 | JACOBS CINDY President & CMO | Grant or award · Stock Option (right to buy) | +32,500 | 32,500 | ||
| 2022-01-03 | Stewart Richard Alistair Executive Chairman | Grant or award · Performance Restricted Stock Unit (PRSU) | +45,000 | 45,000 | ||
| 2022-01-03 | Stewart Richard Alistair Executive Chairman | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2022-01-03 | Bencich John CEO | Grant or award · Performance Restricted Stock Unit (PRSU) | +50,000 | 50,000 | ||
| 2022-01-03 | Bencich John CEO | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2022-01-03 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 | |||
| 2022-01-03 | SVB FINANCIAL GROUP 10% owner | Other acquisition · Convertible Debt (PIK Amount) | +0 |
Page 11 of 36 · 715 trades